Non-clinical safety of dipma-AP to support chronic pain indication. POP: 09/17/2020 to 01/16/2021.
Ended Awarded Last action
- Contract number
- 75N95020F00003
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,890
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR17200221 · Posted Apr 7, 2020
- Contract value 100% obligated
- $2,890.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Columbus, OH 43201, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$153,539 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $156,429 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Battelle Memorial Institute, doing business as Battelle. The contract, which has a period of performance from September 17, 2020 to January 16, 2021, is for non-clinical safety studies of the compound DIPMA-AP to support its development for a chronic pain indication. The potential value of the award is $2,890.18. This contract is part of a larger IDIQ vehicle entitled "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" which allows NCATS to task Battelle, a nonprofit research and development organization, to provide a range of services including scientific research, engineering, and technical support to advance federal initiatives in areas such as health, energy, and the environment.
Quick answers
Who was awarded contract 75N95020F00003?
75N95020F00003 was awarded to Battelle Memorial Institute by National Institute on Drug Abuse (National Institutes of Health) on September 17, 2020.
How much is contract 75N95020F00003 worth?
The government has obligated $2,890 on 75N95020F00003.
Which agency awarded contract 75N95020F00003?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020F00003, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95020F00003 an order under another contract?
Yes. 75N95020F00003 is a delivery order under HHSN271201700015I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract 75N95020F00003 competed?
The extent of competition for 75N95020F00003 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award